Medium Chain Triglycerides (MCTs) are made up of medium-chain fatty acids. goMCT® contains C8 and C10 MCTs, the most effective in converting to ketones, a potent alternative energy source for the brain and muscles. MCT Octane Powder is a new energy supplement by Celarity that offers the research-proven benefits in the areas of energy, focus and performance in a convenient, ready-to-use powder.
MCT Octane Powder optimizes ketone production, a less oxidative energy source. As a result, it fuels the body with healthy fats for natural and sustainable energy. MCT Octane Powder also contains acacia fiber, a prebiotic that aids in gut health. Together, the MCT and acacia fiber optimize thegut brain axis. And with no additives or fake ingredients, Celarity MCT Oil Powder is the best low-carb powder to support your keto lifestyle. And our MCT powder is easier to take with you on the go than traditional MCT oils.
WHAT IS MCT OCTANE POWDER?
WHAT ARE MCTs?
Due to the collective significance of the benefits associated with MCTs, it has been suggested that MCTs may have a role to play in the management of healthy body weight, body composition, and exercise performance.[1,3-5] Although most of the clinical research has utilized the oil form of MCT, anecdotal feedback suggests that a powdered delivery form offers the same benefits as the oil but with better gut tolerability (or less GI distress) and is more convenient to the consumer. To convert the oil to a solid powder form, the MCT oil is spray-dried and micro-encapsulated with acacia fiber.
INGREDIENTS THAT WORK
MCTs AND WEIGHT MANAGEMENT
Human studies utilizing a 3 g powdered dose of MCT are limited; however, the results of a 90-day study (2007) in moderately overweight free-living type 2 diabetic subjects in urban China (N = 40) suggested that moderate consumption of MCTs might be linked to improved risk factors in this population. The test group consumed 18 g/day of MCT oil; the controls were given corn oil. While the corn oil group had no significant changes, the MCT group showed an across-time (0, 45, 90 days) reduction in body weight and waist circumference, an increase in serum C-peptide concentration, a reduction in homeostasis model assessment of insulin resistance, and a decrease in serum cholesterol concentration (P < .05, repeated measures). The MCT group also showed a reduction in daily caloric intake, a phenomenon similar to that identified in a 1983 three-part rat study. In the study, diabetic rats that ingested MCTs reduced their food intake within two hours while diabetic rats that consumed long-chain triglycerides in the form of corn oil reduced their caloric-intake in two to four hours.
A 2013 systematic review and meta-analysis of randomized controlled studies on the effect of MCTs versus long-chain triacylglycerols (LCTs) on body composition in adults (11 studies, five deemed not to have any bias) demonstrated that individuals who replaced dietary LCTs with MCTs showed “significantly reduced body weight (WMD, -0.69 kg; 95% confidence interval [CI], -1.1 to -0.28; p = 0.001); body fat (-0.89 kg; 95% CI, -1.27 to -0.51; p < 0.001), and WC (waist circumference) (-1.78 cm; 95% CI, -2.4 to -1.1; P < 0.001).” However, the reviewers stated that “overall quality of the evidence was low-to-moderate” and that “trials with a crossover design were responsible for the heterogeneity.”* Research into the effect of MCTs has been ongoing since 2013. Though not having human subjects limits relevancy, a 2018 study (similar to the 2007 human study noted prior) demonstrated a positive effect on serum lipids of MCTs combined with a controlled diet. This eight-week study on streptozotocin-induced type 2 diabetes (T2DM) rats given a high-fat or a low-fat diet with either soybean oil or MCT oil showed that MCT oil in conjunction with a high-fat diet lowered serum low-density lipoprotein cholesterol (LDL-C), non-esterified fatty acids, and liver total cholesterol while it increased serum high-density lipoprotein cholesterol (HDL-C) and the HDL-C/LDL-C ratio. In comparison to T2DM rats fed a high-fat soybean oil diet, the rats on the low-fat MCT oil diet had lower body weight and reproductive white adipose tissue. Also, compared to the T2DM rats given the low-fat soybean oil diet, the T2DM rats on the low-fat MCT oil diet showed higher hepatic acyl-CoA oxidase activities (an enzyme key to peroxisomal beta-oxidation).
MCTs AND THE KETOGENIC DIET
MCTs have also been suggested to be a beneficial adjunct to a ketogenic diet because of their ability to convert to ketone bodies. Concluding in a March 2018 published narrative review that the number and scope of studies related to the use of nutritional supplements to induce ketosis and reduce symptoms associated with keto induction were inadequate, the same researchers performed a randomized, double-blind, placebo-controlled trial (N = 28) in May 2018 to determine whether MCTs reduce time to nutritional ketosis. Secondarily, the researchers wanted to see if MCTs reduce symptoms that commonly occur as the body transitions from a glucose-dominant fuel system to reliance on ketones and whether mood is affected. Participants were randomized into two groups and received 30 mL/day of MCT or sunflower oil for 20 days in conjunction with a ketogenic diet. Although differences between the MCT and sunflower oil groups failed to meet significance (P = 0.30), mean time to nutritional ketosis was one day shorter in the MCT group. Compared to the control group, the MCT group had comparatively lower symptoms associated with ketoinduction for some but not all days. The difference between groups for mood was unclear.
MCTs AND BRAIN HEALTH
Animal and human studies have explored the potential role of MCTs in increasing ketones and supporting brain health. In a study of adults (N = 20) with cognitive impairment who were given MCTs or placebo, significant increases in betahydroxybutyrate (BHB)—one of the three primary ketone bodies—were observed 90 minutes post-treatment when recall tests were administered. In a 90-day, randomized, double-blind, placebo-controlled, parallel group study, subjects (N = 152) with mild-to-moderate Alzheimer’s disease were given an oral ketogenic MCT compound to determine if ketosis could affect cognitive performance. Significantly elevated levels of BHB were seen two hours after administration when compared to placebo. Correspondingly, elevated BHB levels resulted in significant differences in Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) scores when compared to placebo.
MCTs AND EXERCISE
A 2018 study demonstrated increased mitochondrial biogenesis and metabolism thereby improving exercise performance in mice. Research on MCTs as fuel for exercise also continues to emerge. A small study using recreational athletes as subjects (N = 8) suggested that when consuming MCTs, blood lactate levels and rate of perceived exertion during moderate-intensity exercise were significantly reduced. Another small study suggested that endurance-trained cyclists (N = 6) who consumed MCTs during moderate-intensity exercise for two hours had significant improvements in timetrial performances during subsequent high-intensity exercise. Additional research in larger trials is necessary before any definitive conclusions can be drawn related to the effects of MCTs on exercise performance enhancement.
MCTs AND GUT HEALTH
NuVision Health Center’s MCT Octane Powder contains a patented medium-chain triglyceride powder with a high caprylic and capric acid content plus acacia fiber. This fiber acts as a prebiotic that promotes changes in the composition and/or activity in the gastrointestinal microflora. Acacia fiber resists digestion in the small intestine; it is fermented by the gut microflora in the colon to promote overall gut health. With the knowledge of the importance of the role of gut-brain axis in health, this formula combines MCT and acacia fiber to potentially optimize this axis.
Suggested use:Mix the contents of one stick pack in 6-12 oz of water or beverage of choice, or use as directed by your healthcare practitioner.
Storage: Keep in cool, dry place out of reach of children.
Does not contain:Wheat, gluten, yeast, corn, soy, animal or dairy products, fish, shellfish, peanuts, tree nut protein, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.
1. Clegg ME. Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performance. Int J Food Sci Nutr. 2010 Nov;61(7):653-79. [PMID: 20367215]
2. Han JR, Deng B, Sun J, et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007 Jul;56(7):985-91. [PMID: 17570262]
3. Mumme K, Stonehouse W. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J Acad Nutr Diet. 2015 Feb;115(2):249-63. [PMID: 25636220]
4. Babayan VK. Medium chain triglycerides and structured lipids. Lipids. 1987 Jun;22(6):417-20. [PMID: 3112486]
5. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. 1982 Nov;36(5):950-62. [PMID: 6814231]
6. Friedman MI, Edens NK, Ramirez I. Differential effects of medium-and long-chain triglycerides on food intake of normal and diabetic rats. Physiol Behav. 1983 Dec;31(6):851-5. [PMID: 6686684]
7. Bueno NB, de Melo IV, Florêncio TT, et al. Dietary medium-chain triacylglycerols versus long-chain triacylglycerols for body composition in adults: systematic review and meta-analysis of randomized controlled trials. J Am Coll Nutr. 2015;34(2):175-83. [PMID: 25651239]
8. Sung MH, Liao FH, Chien YW. Medium-chain triglycerides lower blood lipids and body weight in streptozotocin-induced type 2 diabetes rats. Nutrients. 2018 Jul 26;10(8). pii: E963. [PMID: 30049949]
9. Harvey CJDC, Schofield GM, Williden M. The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review. PeerJ. 2018 Mar 16;6:e4488. [PMID: 29576959]
10. D C Harvey CJ, Schofield GM, Williden M, et al. The effect of medium chain triglycerides on time to nutritional ketosis and symptoms of keto-induction in healthy adults: a randomised controlled clinical trial. J Nutr Metab. 2018 May 22;2018:2630565. [PMID: 29951312]
11. Reger MA, Henderson ST, Hale C, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004 Mar: 25 (3):311-4. [PMID: 15123336]
12. Henderson ST, Vogel JL, Barr LJ, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo controlled, multicenter trial. Nutr Metab (Lond). 2009 Aug 10;6:31. [PMID: 19664276]
13. Wang Y, Liu Z, Han Y, et al. Medium chain triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism. PLoS One. 2018 Feb 8;13(2):e0191182. [PMID: 29420554]
14. Nosaka N, Suzuki Y, Nagatoishi A, et al. Effect of ingestion of medium-chain triacylglycerols on moderate- and high-intensity exercise in recreational athletes. J Nutr Sci Vitaminol (Tokyo). 2009 Apr;55(2):120-5. [PMID: 19436137]
15. Van Zyl CG, Lambert EV, Hawley JA, et al. Effects of medium-chain triglyceride ingestion on fuel metabolism and cycling performance. J Appl Physiol (1985). 1996 Jun;80(6):2217-25. [PMID: 8806933]
16. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013 Apr 22;5(4):1417-35. [PMID: 23609775]